App-Quantinova.ai

A CASE OF PULMONARY EMBOLISM FROM SUPERFICIAL VENOUS THROMBOSIS WITH AN UPPER EXTREMITY SOURCE IN A 35‐YEAR‐OLD FEMALE ON ORAL CONTRACEPTIVE PILLS

BRYAN JEFFREY MANZANA - Asian Pacific Society of Respirology (APSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

rivaroxaban

RISK OF SYMPTOMATIC VENOUS THROMBOEMBOLISM IN PATIENTS FOLLOWING APPENDECTOMY: A NATIONWIDE COHORT STUDY

WEI-SHENG CHUNG - Asian Pacific Society of Respirology (APSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

GENETIC VARIANT OF CYP4V2 ASSOCIATED WITH VENOUS THROMBOEMBOLISM: A CASE‐CONTROL STUDY

YONGJIAN YUE - Asian Pacific Society of Respirology (APSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

TRENDS IN HOSPITALIZATION AND MORTALITY OF VENOUS THROMBOEMBOLISM FROM 2007 TO 2016 IN CHINA

ZHU ZHANG - Asian Pacific Society of Respirology (APSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

GENETIC ASSOCIATION OF RS2227589 POLYMORPHISM WITH PULMONARY EMBOLISM RISK IN CHINESE POPULATION

YONGJIAN YUE - Asian Pacific Society of Respirology (APSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

The influence of venous thromboembolism on prognosis of esophageal cancer patients.

En Amada - American Society of Clinical Oncology Gastrointestinal (ASCO GI) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Risk factor of thrombosis and impact on prognosis in patients with pancreatic cancer receiving chemotherapy.

Kazunaga Ishigaki - American Society of Clinical Oncology Gastrointestinal (ASCO GI) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Viral hepatitis associated hepatocellular carcinoma outcomes with Y-90 radioembolization.

Jessica M. Frakes - American Society of Clinical Oncology Gastrointestinal (ASCO GI) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Thromboembolism incidence in patients with gastrointestinal tract cancer receiving chemotherapy: A single-institutional retrospective cohort analysis.

Ayane Oba - American Society of Clinical Oncology Gastrointestinal (ASCO GI) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Review of efficacy and safety of the new oral anticoagulants (NOACS) in the treatment of venous thromboembolism in gastrointestinal (GI) oncology patients.

Hitendra Patel - American Society of Clinical Oncology Gastrointestinal (ASCO GI) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

rivaroxaban

The adverse effects of androgen-deprivation therapy: Comparison between gonadotropin-releasing hormone agonists and orchiectomy in the SEER-Medicare population.

Maxine Sun - American Society of Clinical Oncology Genitourinary (ASCO GU) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Androgen Tear

Incidence, characteristics, and implications of thrombo-embolic events in patients with urothelial carcinoma of the bladder undergoing neoadjuvant chemotherapy.

Wilhelmina CM Duivenvoorden - American Society of Clinical Oncology Genitourinary (ASCO GU) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Venous thromboembolism (VTE) risk in patients with localized urinary tract tumors (UTT).

Jorge Ramos - American Society of Clinical Oncology Genitourinary (ASCO GU) , 2016

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

The relationship between travel distance to cystectomy and likelihood of readmission.

Troy Sukhu - American Society of Clinical Oncology Genitourinary (ASCO GU) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Preclinical Evaluation of Safety and Biodistribution of Red Cell Microparticles (RMP): A Novel Hemostatic Agent

Ashish Rehni - American Society of Hematology (ASH) , 2018

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Hemostatic Solution

Evaluation of Phenotype-Genotype Correlation in Two Common PIEZO1 Mutations p.R2456H and p.L2495_E2495dup

Mary Risinger - American Society of Hematology (ASH) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

Regulatory Genetic Variation at the S100B Gene Associates with Vaso-Occlusive Manifestations in Sickle Cell Disease

Xu Zhang - American Society of Hematology (ASH) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Hydroxyurea

Sickle Cell Disease and Venous Thromboembolism: Hospital Mortality, Length of Stay and Cost

Michael Rainone - American Society of Hematology (ASH) , 2018

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

High Incidence and Recurrence Rate of Venous Thromboembolic Events in Patients with Sickle Cell Disease

Bart J. Biemond - American Society of Hematology (ASH) , 2018

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Coagulation Profile of Sickle Cell Patients with Leg Ulcers

Ugochi Olivia Ogu - American Society of Hematology (ASH) , 2018

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Filters

7277 Abstracts